1. Home
  2. NABL vs VRDN Comparison

NABL vs VRDN Comparison

Compare NABL & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NABL
  • VRDN
  • Stock Information
  • Founded
  • NABL 2000
  • VRDN 2006
  • Country
  • NABL United States
  • VRDN United States
  • Employees
  • NABL N/A
  • VRDN N/A
  • Industry
  • NABL Computer Software: Prepackaged Software
  • VRDN Medical Specialities
  • Sector
  • NABL Technology
  • VRDN Health Care
  • Exchange
  • NABL Nasdaq
  • VRDN Nasdaq
  • Market Cap
  • NABL 1.8B
  • VRDN 1.5B
  • IPO Year
  • NABL N/A
  • VRDN N/A
  • Fundamental
  • Price
  • NABL $9.24
  • VRDN $18.13
  • Analyst Decision
  • NABL Strong Buy
  • VRDN Buy
  • Analyst Count
  • NABL 2
  • VRDN 12
  • Target Price
  • NABL $15.75
  • VRDN $36.44
  • AVG Volume (30 Days)
  • NABL 765.7K
  • VRDN 1.6M
  • Earning Date
  • NABL 02-20-2025
  • VRDN 02-25-2025
  • Dividend Yield
  • NABL N/A
  • VRDN N/A
  • EPS Growth
  • NABL 72.50
  • VRDN N/A
  • EPS
  • NABL 0.20
  • VRDN N/A
  • Revenue
  • NABL $458,053,000.00
  • VRDN $302,000.00
  • Revenue This Year
  • NABL $12.07
  • VRDN $2.55
  • Revenue Next Year
  • NABL $10.50
  • VRDN N/A
  • P/E Ratio
  • NABL $46.24
  • VRDN N/A
  • Revenue Growth
  • NABL 11.93
  • VRDN N/A
  • 52 Week Low
  • NABL $8.92
  • VRDN $11.40
  • 52 Week High
  • NABL $15.49
  • VRDN $27.20
  • Technical
  • Relative Strength Index (RSI)
  • NABL 35.65
  • VRDN 44.39
  • Support Level
  • NABL $8.92
  • VRDN $16.60
  • Resistance Level
  • NABL $9.72
  • VRDN $21.58
  • Average True Range (ATR)
  • NABL 0.22
  • VRDN 1.00
  • MACD
  • NABL 0.03
  • VRDN -0.16
  • Stochastic Oscillator
  • NABL 40.37
  • VRDN 30.72

About NABL N-able Inc.

N-able Inc is a provider of cloud-based software solutions for managed service providers (MSPs), enabling them to support digital transformation and growth for small and medium-sized enterprises. With a flexible technology platform and powerful integrations, N-able makes it easy for MSPs to monitor, manage, and protect their end-customer systems, data, and networks. The company's growing portfolio of management, security, automation, and data protection solutions is built for IT services management professionals. Geographically, the majority of revenue is from the United States. it also has a presence in the United Kingdom and all other International regions.

About VRDN Viridian Therapeutics Inc.

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate VRDN-001 is an insulin-like growth factor-1 receptor (IGF-1R) monoclonal antibody (mAb) being developed for the potential treatment for patients with thyroid eye disease.

Share on Social Networks: